Under the terms of the partnership agreement, One Nucleus will support and profile the life science and healthcare start-ups participating in the Start Codon accelerator programme.
Founded in April 2019, Start Codon aims to identify and recruit high potential life science and healthcare companies from across the UK and beyond, provide seed-funding, and leverage the world-class resources of the Cambridge Cluster to reduce risk and prepare them for a successful Series A fundraise. Commencing 6th January 2020, One Nucleus will provide Start Codon cohort companies with gold membership benefits, over 12 months, focused on raising their profile and helping to access new industry contacts. Gold membership benefits include an online company profile on One Nucleus’ ‘Member Directory’, discounted training in events such as Genesis and ON Helix, preferred supplier agreement discounts and participation in special interest groups. Given One Nucleus’ extensive network of life science start-ups, the partnership will also help Start Codon secure disruptive platform technology companies for its programme.
Start Codon CEO, Dr Jason Mellad, was participating in the “Meeting Biotech Rising Stars” panel session at the One Nucleus Genesis conference yesterday (December 11th) at the QEII Centre, Westminster, London. More information can be found here.
Dr Jason Mellad, CEO at Start Codon, said: “Like Start Codon, One Nucleus is committed to playing an active and supportive role in enabling the success of the UK life science cluster, particularly that in the East of England and London. Having One Nucleus membership benefits will be extremely valuable to our cohort, particularly for developing a network of industry leading contacts.”
Tony Jones, CEO at One Nucleus, said: “One Nucleus can provide local, UK-wide and international connectivity to enable companies to maximise their performance within the life sciences and healthcare industry. Therefore, we are excited to partner with Start Codon to help facilitate the next generation of innovative and entrepreneurial companies.”